ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer
Ann Surg Oncol
.
2025 Feb;32(2):967-968.
doi: 10.1245/s10434-024-16606-w.
Epub 2024 Dec 2.
Authors
Leah K Winer
1
2
,
Austin D Williams
3
Affiliations
1
Division of Surgical Oncology, Department of Surgery, University of Kentucky, Lexington, KY, USA.
2
Division of Breast Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
3
Division of Breast Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.
[email protected]
.
PMID:
39623191
DOI:
10.1245/s10434-024-16606-w
No abstract available